Pipeline
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Pipeline
COVID-19 Vaccine
| Pipeline | Antigen gene | Basic research | Preclinical experiment | Phase of Clinical trial | ||
|---|---|---|---|---|---|---|
| Phase Ⅰ | Phase Ⅱ | Phase Ⅲ | ||||
| AdCLD-CoV19-1 | SARS-CoV-2 Spike protein |
NCT Identifier :
|
||||
| AdCLD-CoV19-1 OMI | SARS-CoV-2 B.1.1.529 spike protein 재조합유전자 |
NCT Identifier : TBA
|
||||
-
AdCLD-CoV19-1
SARS-CoV-2 Spike protein
Basic research Preclinical experiment Phase Ⅰ Phase Ⅱ Phase Ⅲ NCT Identifier :
- Indication : COVID-19 prevention
- Clinical Trial Stage : Phase IIb Clinical Trial
- Clinical Trial Purpose : To evaluated safety and immunogenicity of AdCLD-CoV19
- Clinical Trial Result : In progress
-
AdCLD-CoV19-1 OMI
SARS-CoV-2 B.1.1.529 spike protein 재조합유전자
Basic research Preclinical experiment Phase Ⅰ Phase Ⅱ Phase Ⅲ NCT Identifier : TBA
- Indication : COVID-19 Omicron prevention
- Clinical Trial Stage : Phase1/2 IIb Clinical Trial
- Clinical Trial Purpose : To evaluated safety and immunogenicity of AdCLD-CoV19 OMI
- Clinical Trial Result : In progress
